stockrow
Saturday 7 November 2026
Export ZURA’s income statement to Excel — free account
Zura Bio Limited
ZURA Healthcare Biotechnology
- EPS
- +3.71%
- Free cash flow
- −26.2%
Quarter to September 2026, against a year earlier
4.11
0.39
+10.48%
Follow ZURA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(79.52%) | (59.52%) | (71.76%) | (85.05%) | |
| (67.71%) | (52.92%) | (62.74%) | (72.21%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(99.33%) | (49.28%) | (59.92%) | (69.94%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.69) | (0.65) | (0.61) | (0.64) | |
Free Cash Flow |
(64.93) | (72.75) | (77.63) | (81.69) | |
Capital Expenditures |
(0.11) | (0.08) | (0.09) | (0.09) | |
| Other line items | |||||
Cash ROIC |
(30.78%) | (16.44%) | (19.30%) | (22.36%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.65 | 0.68 | 0.67 | 0.67 | |
Depreciation/Fixed assets |
0.39 | 0.45 | 0.41 | 0.44 | |
Capex/Depreciation |
(2.31) | (1.37) | (1.41) | (1.34) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.69) | (0.65) | (0.61) | (0.64) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026